Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global leading healthcare company headquartered in China. The group focuses on the research, development, production, and distribution of pharmaceuticals, medical devices, and healthcare services on a global scale.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Fosun Pharmaceutical H is scheduled to report its next quarterly earnings on 11/03/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Fosun Pharmaceutical H last reported quarterly earnings on 8/25/2026 (Q2 2026). Earnings per share (EPS) came in at 0.37 HKD.
Across its last 3 earnings reports, Shanghai Fosun Pharmaceutical H stock moved by ±2% on average the following day. The largest reaction was +3.9% on 03/24/2026; 3 of 3 reactions were positive.
Shanghai Fosun Pharmaceutical H has beaten analyst EPS estimates in 5 of its last 6 evaluated quarters (beat rate: 83.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.